Four years ago, my life changed after a heart attack at the age of 33. While a quick coronary angioplasty meant my heart was mostly fine, the tests conducted at the same time revealed a bigger chronic ...
Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.
April 28, 2006 — The US Food and Drug Administration (FDA) has approved a liquid-based Papanicolaou test system for use in collecting and preparing cervical/vaginal specimens; a continuous monitoring ...
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 ...
StockStory.org on MSN
5 insightful analyst questions from DexCom’s Q1 earnings call
DexCom’s first quarter saw revenue growth driven by new product launches and increased adoption, particularly among people with type 2 diabetes who are not on insulin. Management highlighted progress ...
After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results